Stock listing

OTC:BTAX Biostax Corp. Stock

Follow Biostax Corp. into a list and get an email when it puts out news.

Share price · OTC:BTAX

$0.0002 USD 0.0000 (0.0%)

Close on Oct 23, 2026

Past year +100.0% · daily closes, Oct 23, 2025 – Oct 23, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDOct 23, 2026
Volume
163 sharesOct 23, 2026
Market cap
$15,743 USDAt the close on Oct 23, 2026 · price × 78.71M shares outstanding
52-week range
$0.0001 – $0.0002 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Traded on an average day
$0 USDMedian day 0 shares · 62 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026
Biostax Corp. logo

Daily closes

Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:BTAX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.0002163
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002110
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002+0.0001+100.0%$0.0002$0.0002$0.0002278
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00012,194
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00014,791
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
Ticker
OTC:BTAX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration

Feb 21, 2025

Immune Therapeutics, Inc. Provides Shareholder Update on 14A

May 15, 2019

Immune Therapeutics welcomes Kevin Phelps to Board of Directors

Jan 9, 2019

Research on Lodonal (“LDN”) for HIV-related GI complications, and Inflammation featured in A&U Magazine

Dec 13, 2018

Immune Therapeutics Welcomes Amb. Jack Brewer to the Board of Directors

Sep 6, 2018

Immune Therapeutics Labeled as a Pioneer in Forbes Article Discussing Booming Pet Care Industry

Sep 5, 2018

Renown HIV specialist Dr. Gary Blick Joins Immune Therapeutics Advisory Board

Aug 23, 2018

Immune Therapeutics Adds Former United States Assistant Surgeon General Dr. Roscoe Moore to Board of Directors

Aug 7, 2018

Immune Therapeutics Inc Announces Publication of Peer Reviewed Scientific Paper Describing Low-Dose Naltrexone (LDN): A Promising Treatment in Immune-Related Diseases and Cancer Therapies

Jul 25, 2018

Research on Lodonal for HIV related GI complications featured in Plus Magazine

Jul 19, 2018

All Biostax Corp. news

Biostax Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
106 in all · newest Feb 21, 2025 · oldest 2012

Log in to ask 6ix AI your own questions about Biostax Corp.